TP53 and glioblastoma: Notably, in the P53-mutant GBM cell line U251 [29], JN-PROTAC exhibited anti-tumor activity through MAGL degradation (Supplementary Fig. 7H), indicating that MAGL degradation can promote cell death independently of P53-mediated pathways (Fig. 2J).